<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The presence of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> and the related condition <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> present a challenge in cardiac surgery where measured anticoagulation may not reflect the in vivo patient status of hypercoagulation </plain></SENT>
<SENT sid="1" pm="."><plain>We report the successful management of a patient with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> presenting for aortic valve replacement and coronary revascularisation </plain></SENT>
<SENT sid="2" pm="."><plain>We used <z:chebi fb="5" ids="28304">heparin</z:chebi> for anticoagulation, specialised additional tests of anticoagulation and a reduced protamine dose </plain></SENT>
<SENT sid="3" pm="."><plain>We also used <z:chebi fb="0" ids="48669">tranexamic acid</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>The clinical problems with anticoagulation in patients with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> include <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> choice, measurement of adequate anticoagulation, antifibrinolytic usage, protamine dosing and blood product transfusion </plain></SENT>
</text></document>